September 13, 2021

Weed Stocks Investing For the Rest of 2021

Midas Letter
Midas Letter
Weed Stocks Investing For the Rest of 2021

According to recent forecasts, the cannabis industry could double by 2025. The U.S. cannabis industry could exceed $45 billion in annual sales alone. With that opportunity on the table, many new investors are seeking to profit. But as the industry has consolidated for most of the year, is 2021 now a good time to invest in weed stocks?

As states and countries decriminalize or legalize marijuana and its associated derivatives, investors have a growing number of opportunities to play their hand according to their preferences and opinions.

Of course, with large opportunities come risks. So whether you’re a fresh & green pot stock investor or a seasoned veteran hurt by cannabis bear markets in the past, we talk with an expert that has been analyzing the industry from the beginning in an attempt to form an investment guide in today’s cannabis market.

Bruce Campbell is the Portfolio Manager of the StoneCastle Cannabis Growth Fund and the Chief Investment Officer of Plant-Based Investment Corp. (formerly Cannabis Growth Opportunity Corp). His cannabis fund has a bias towards US operators and favours undervalued companies compared with their peers. His funds top 3 holdings as of July 31 are:

  1. Green Thumb Industries Inc (CNSX:GTII, OTCMKTS:GTBIF)
  2. Verano Holdings Corp (CNSX:VRNO, OTCMKTS:VRNOF)
  3. Lowell Farms Inc (CNSX:LOWL, OTCMKTS:LOWLF)

Related Articles


Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.